Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Research Article

Prediction of Different Risk Factors in Relation to Hyperlipidemia Using Framingham Risk Score and Cholesterol Risk Score in a Tertiary Care Hospital

In Press, (this is not the final "Version of Record"). Available online 10 July, 2024
Author(s): Abrar Ahmad Zargar, Ranjeet Kumar* and Amit Sharma
Published on: 10 July, 2024

Article ID: e100724231817

DOI: 10.2174/0115733998284967240412104822

Price: $95

Abstract

Background: A condition that affects the circulatory system of the human body is referred to as a cardiovascular disease (CVD). Cardiovascular diseases (CVDs) are responsible for a significant number of fatalities globally. Annually, CVDs result in the demise of 17.9 million people, which accounts for 31% of all fatalities on a global scale.

Objective: The objective of the study was to assess the demographic profile of diabetic and nondiabetic patients suffering from cardiovascular disease. The aim of the study is to predict risk factors in relation to hyperlipidaemia using two different scales, the Framingham Risk Scale (FRS) and the Cholesterol Risk Calculator (CRC), and to determine the frequency of hypercholesterolemia in relation to CVD.

Methods: A cross-sectional study was conducted in Guru Gobind Singh Medical College and Hospital, Punjab, India.

Results: The mean age of patients was found to be M= (51.23), SD= (9.348) years, and among 331 patients (52.6%) were female patients. The mean of Framingham Risk Score was found to be (29.07%). The Framingham Risk Score was found significant with gender and calorie intake below the recommended dietary allowances of the patient (p=0.001). The Framingham Risk Score was found significant with physical activity and employment status of the patients (p= 0.001). In linear regression, the Framingham Risk Score was found significant with the lipid profile of the patients (p=0.001) i.e., the higher the value of cholesterol level, the higher the Framingham Risk Score. The chi-square test showed a significant relation between Cholesterol Risk Score and employment status, physical activity, calorie intake, gender, and occupation of the patients (p=0.001, p=0.001, p=0.001, p=0.004) respectively.

Conclusion: The present study demonstrated that patients with high Framingham risk score and cholesterol risk score are at increased risk of diabetes and cardiovascular disease. The present study concludes that the FRS is higher in patients below RDA, patients doing low physical activity, and sedentary workers. In order to provide proper assistance and counselling, healthcare professionals must continuously analyze each patient's risk factor for CVD and barriers to healthy and preventive behaviors. There is a lack of comprehensive studies comparing the effectiveness of the Framingham Risk Score and Cholesterol Risk Score in predicting hyperlipidemia and associated cardiovascular risks within the context of a tertiary care hospital setting.

[1]
Wang T, Li Y, Zheng X. Association of socioeconomic status with cardiovascular disease and cardiovascular risk factors: a systematic review and meta-analysis. J Public Health 2023; 2018(0123456789): 1-15.
[http://dx.doi.org/10.1007/s10389-023-01825-4] [PMID: 36714072]
[2]
Kundu J, Kundu S. Cardiovascular disease (CVD) and its associated risk factors among older adults in India: Evidence from LASI Wave 1. Clin Epidemiol Glob Heal 2022; 13: 100937.
[http://dx.doi.org/10.1016/j.cegh.2021.100937]
[3]
Zubair F, Nawaz SK, Nawaz A, Nangyal H, Amjad N, Khan MS. Prevalence of cardiovascular diseases in Punjab, Pakistan: a cross-sectional study. J Public Health 2018; 26(5): 523-9.
[http://dx.doi.org/10.1007/s10389-018-0898-4]
[4]
Al-Nohair S, Babiker N, Al-Ahmari D, et al. Cross-sectional study of cardiovascular risk factors among male and female medical students in qassim university – college of medicine saudi arabia. J Med Sci 2020; 8(E): 439-45.
[http://dx.doi.org/10.3889/oamjms.2020.4501]
[5]
Maini E, Venkateswarlu B, Maini B, Marwaha D. Machine learning–based heart disease prediction system for Indian population: An exploratory study done in South India. Med J Armed Forces India 2021; 77(3): 302-11.
[http://dx.doi.org/10.1016/j.mjafi.2020.10.013] [PMID: 34305284]
[6]
Mohd N, Mohd Z, Krishnapillai A, Rahimi M, Hassan C. Predictors of cardiovascular disease using framingham risk score in a rural population. Malaysian J Med Heal Sci 2022; 18(June): 340-7.
[http://dx.doi.org/10.47836/mjmhs18.8.43]
[7]
Banitalebi E, Mardaniyan Ghahfarrokhi M, Faramarzi M, Nasiri S. The effects of 10-week different exercise interventions on Framingham risk score and metabolic syndrome severity scores in overweight women with type 2 diabetes. Shahrekord Univ Med Sci J 2018; 21(1): 1-8.
[http://dx.doi.org/10.34172/jsums.2019.01]
[8]
Al-Shamsi S. Performance of the Framingham coronary heart disease risk score for predicting 10-year cardiac risk in adult United Arab Emirates nationals without diabetes: a retrospective cohort study. BMC Fam Pract 2020; 21(1): 175.
[http://dx.doi.org/10.1186/s12875-020-01246-2] [PMID: 32847496]
[9]
Triantafyllidis A, Kondylakis H, Katehakis D, et al. Deep learning in mHealth for cardiovascular disease, diabetes, and cancer : systematic review. JMIR Mhealth Uhealth 2022; 10(4): e32344.
[http://dx.doi.org/10.2196/32344] [PMID: 35377325]
[10]
Mohan V, Venkatraman JV, Pradeepa R. Epidemiology of cardiovascular disease in type 2 diabetes: the Indian scenario. J Diabetes Sci Technol 2010; 4(1): 158-70.
[http://dx.doi.org/10.1177/193229681000400121] [PMID: 20167181]
[11]
Praveen D, Peiris D, MacMahon S, et al. Cardiovascular disease risk and comparison of different strategies for blood pressure management in rural India. BMC Public Health 2018; 18(1): 1264.
[http://dx.doi.org/10.1186/s12889-018-6142-x] [PMID: 30442122]
[12]
Hernández-Vásquez A, Vargas-Fernández R, Chacón-Diaz M. Association between altitude and the framingham risk score: a cross-sectional study in the peruvian adult population. Int J Environ Res Public Health 2022; 19(7): 3838.
[http://dx.doi.org/10.3390/ijerph19073838] [PMID: 35409522]
[13]
Aggarwal P, Sinha SK, Khanra D, et al. Comparison of original and modified Q risk 2 risk score with Framingham risk score - An Indian perspective. Indian Heart J 2021; 73(3): 353-8.
[http://dx.doi.org/10.1016/j.ihj.2021.01.016] [PMID: 34154755]
[14]
Yadav R, Yadav RK, Sarvottam K, Netam R. Framingham risk score and estimated 10-year. J Altern Complement Med 2017; 23(9): 730-7.
[http://dx.doi.org/10.1089/acm.2016.0309] [PMID: 28437144]
[15]
Kumari N, Verma DK, Binawara BK. A study to assess the future 10-year cardiovascular and8-year diabetic risk by using Framingham heartscale in prediabetic subjects. Int J Endocrinol 2022; 18(5): 245-50.
[http://dx.doi.org/10.22141/2224-0721.18.5.2022.1182]
[16]
Jahangiry L, Farhangi MA, Rezaei F. Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome. J Health Popul Nutr 2017; 36(1): 36.
[http://dx.doi.org/10.1186/s41043-017-0114-0] [PMID: 29132438]
[17]
Medindia team. Cholesterol risk calculator. Medindia. 2023. Available from: https://www.medindia.net/patients/calculators/cholesterol-risk-calculator.asp Accessed January 19, 2023.
[18]
Naing NN. Determination of sample size. Malays J Med Sci 2003; 10(2): 84-6.
[PMID: 23386802]
[19]
Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97(18): 1837-47.
[http://dx.doi.org/10.1161/01.CIR.97.18.1837] [PMID: 9603539]
[20]
Pletcher MJ, Moran AE. Cardiovascular risk assessment. Med Clin North Am 2017; 101(4): 673-88.
[http://dx.doi.org/10.1016/j.mcna.2017.03.002] [PMID: 28577619]
[21]
Jamal M, Abdulrahman A, Farajallah A. Diabetes & metabolic syndrome: clinical research & reviews prevalence of dyslipidemia and factors affecting lipid pro fi le in patients with type 2 diabetes. Diabetes Metab Syndr 2019; 13(4): 2387-92.
[http://dx.doi.org/10.1016/j.dsx.2019.06.009] [PMID: 31405648]
[22]
Sharma A, Baldi A, Kumar Sharma D. Impact of physical activity and cooking oil amongst diabetes with coexisting hypertension patients on economic cost and length of stay: A 1914 patient’s observational study. Int J Clin Pract 2021; 75(7): e14163.
[http://dx.doi.org/10.1111/ijcp.14163] [PMID: 33743546]
[23]
Ramachandran A, Mary S, Yamuna A, Murugesan N, Snehalatha C. High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India. Diabetes Care 2008; 31(5): 893-8.
[http://dx.doi.org/10.2337/dc07-1207] [PMID: 18310309]
[24]
Arabiyat S, Tadros O, Al-Daghastani T, Jaber D. Applying the framingham risk score for cardiovascular diseases in Jordan: a cross-sectional study. Trop J Pharm Res 2022; 21(12): 2667-75.
[http://dx.doi.org/10.4314/tjpr.v21i12.23]
[25]
Samaniyan Bavarsad P, Kheiri S, Ahmadi A. Estimation of the 10-year risk of cardiovascular diseases : using the score, who/ish, and framingham models in the shahrekord cohort study in southwestern Iran. J Tehran Univ Heart Cent 2020; 15(3): 105-12.
[http://dx.doi.org/10.18502/jthc.v15i3.4219] [PMID: 33552205]
[26]
Maharana L, Sateesh Kumar Reddy K, Pattnaik S, et al. A prospective observational study on cardiovascular risk assessment in type-2 diabetes mellitus patients. J Appl Pharm Sci 2019; 9(4): 126-32.
[http://dx.doi.org/10.7324/JAPS.2019.90416]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy